Vinorelbine for Recurrent ALCL-2017
NCT03443128
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
NETWORK
Sponsor class
Conditions
Anaplastic Large Cell Lymphoma
Vinorelbine
Interventions
DRUG:
Vinorelbine
Sponsor
Children's Cancer Group, China